PUBLISHER: Transparency Market Research | PRODUCT CODE: 1285899
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1285899
U.S. OTC Topical Antifungals Market (Drug Class: Azoles, Allylamine, Tolnaftate, Undecylenic Acid, and Others; Dosage Form: Ringworm, Jock Itch, Athlete's Foot, and Others) - Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
U.S. OTC Topical Antifungals Market - Scope of Report
TMR's report on the U.S. OTC Topical Antifungals Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the U.S. OTC Topical Antifungals Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the U.S. OTC Topical Antifungals Market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the U.S. OTC Topical Antifungals market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global U.S. OTC Topical Antifungals market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global U.S. OTC Topical Antifungals market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global U.S. OTC Topical Antifungals market.
The report delves into the competitive landscape of the global U.S. OTC Topical Antifungals market. Key players operating in the U.S. OTC Topical Antifungals Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the U.S. OTC Topical Antifungals Market profiled in this report.
Key Questions Answered in U.S. OTC Topical Antifungals Market Report:
- What is the sales/revenue generated by U.S. OTC Topical Antifungals across all regions during the forecast period?
- What are the opportunities in the global U.S. OTC Topical Antifungals market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
U.S. OTC Topical Antifungals Market - Research Objectives and Research Approach
The comprehensive report on the U.S. OTC Topical Antifungals Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the U.S. OTC Topical Antifungals Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global U.S. OTC Topical Antifungals market.
Table of Contents
1. Preface
- 1.1. Report Scope and Market Segmentation
- 1.2. Research Highlights
2. Assumptions and Research Methodology
- 2.1. Assumptions and Acronyms Used
- 2.2. Research Methodology
3. Executive Summary
4. Market Overview
- 4.1. Introduction
- 4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunity
- 4.3. U.S. OTC Topical Antifungals Market Forecast
- 4.4. U.S. OTC Topical Antifungals Market Outlook
5. Market Outlook
- 5.1. Porter's Five Force Analysis
- 5.2. Pricing Analysis
- 5.3. Disease Prevalence & Incidence Rate
- 5.4. Overview and Application of OTC Products
- 5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact
6. U.S. OTC Topical Antifungals Market Analysis and Forecasts, By Drug Class
- 6.1. Introduction
- 6.2. U.S. OTC Topical Antifungals Market Value Share Analysis, by Drug Class
- 6.3. U.S. OTC Topical Antifungals Market Forecast, by Drug Class
- 6.3.1. Azoles
- 6.3.1.1. Clotrimazole
- 6.3.1.2. Miconazole
- 6.3.1.3. Fluconazole
- 6.3.1.4. Ketokonazole
- 6.3.1.5. Others
- 6.3.2. Allylamine
- 6.3.2.1. Terbinafine
- 6.3.2.2. Butenafine
- 6.3.2.3. Others
- 6.3.3. Tolnaftate
- 6.3.4. Undecylenic Acid
- 6.3.5. Others
- 6.3.1. Azoles
- 6.4. U.S. OTC Topical Antifungals Market Analysis, by Drug Class
- 6.5. U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Drug Class
7. U.S. OTC Topical Antifungals Market Analysis and Forecasts, By Indication
- 7.1. Introduction
- 7.2. U.S. OTC Topical Antifungals Market Value Share Analysis, by Indication
- 7.3. U.S. OTC Topical Antifungals Market Forecast, by Indication
- 7.3.1. Ringworm
- 7.3.2. Jock Itch
- 7.3.3. Athlete's Foot
- 7.3.4. Others
- 7.4. U.S. OTC Topical Antifungals Market Analysis, by Indication
- 7.5. U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Indication
8. U.S. OTC Topical Antifungals Market Analysis and Forecasts, By Dosage Form
- 8.1. Introduction
- 8.2. U.S. OTC Topical Antifungals Market Value Share Analysis, by Dosage Form
- 8.3. U.S. OTC Topical Antifungals Market Forecast, by Dosage Form
- 8.3.1. Creams
- 8.3.2. Gels
- 8.3.3. Ointments
- 8.3.4. Others
- 8.4. U.S. OTC Topical Antifungals Market Analysis, by Dosage Form
- 8.5. U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Dosage Form
9. U.S. OTC Topical Antifungals Market Analysis and Forecasts, By Distribution Channel
- 9.1. Introduction
- 9.2. U.S. OTC Topical Antifungals Market Value Share Analysis, by Distribution Channel
- 9.3. U.S. OTC Topical Antifungals Market Forecast, by Distribution Channel
- 9.3.1. Hospital Pharmacies
- 9.3.2. Retail Pharmacies
- 9.3.3. Online Pharmacies
- 9.4. U.S. OTC Topical Antifungals Market Analysis, by Distribution Channel
- 9.5. U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Distribution Channel
10. Competition Landscape
- 10.1. Market Player - Competition Matrix (By Tier and Size of Companies)
- 10.2. Market Share Analysis, by Company (2022)
- 10.3. Company Profiles
- 10.3.1. Novartis AG
- 10.3.1.1. Company Overview
- 10.3.1.2. Product Portfolio
- 10.3.1.3. SWOT Analysis
- 10.3.1.4. Strategic Overview
- 10.3.2. Merck KGaA
- 10.3.2.1. Company Overview
- 10.3.2.2. Product Portfolio
- 10.3.2.3. SWOT Analysis
- 10.3.2.4. Strategic Overview
- 10.3.3. Dr Reddy's Laboratories Ltd.
- 10.3.3.1. Company Overview
- 10.3.3.2. Product Portfolio
- 10.3.3.3. SWOT Analysis
- 10.3.3.4. Strategic Overview
- 10.3.4. Pfizer, Inc.
- 10.3.4.1. Company Overview
- 10.3.4.2. Product Portfolio
- 10.3.4.3. SWOT Analysis
- 10.3.4.4. Strategic Overview
- 10.3.5. Abbott Laboratories
- 10.3.5.1. Company Overview
- 10.3.5.2. Product Portfolio
- 10.3.5.3. SWOT Analysis
- 10.3.5.4. Strategic Overview
- 10.3.6. Bayer AG
- 10.3.6.1. Company Overview
- 10.3.6.2. Product Portfolio
- 10.3.6.3. SWOT Analysis
- 10.3.6.4. Strategic Overview
- 10.3.7. Sanofi
- 10.3.7.1. Company Overview
- 10.3.7.2. Product Portfolio
- 10.3.7.3. SWOT Analysis
- 10.3.7.4. Strategic Overview
- 10.3.8. Crown
- 10.3.8.1. Company Overview
- 10.3.8.2. Product Portfolio
- 10.3.8.3. SWOT Analysis
- 10.3.8.4. Strategic Overview
- 10.3.1. Novartis AG
List of Tables
- Table 01: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Drug Class, 2017-2031
- Table 02: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Azole, 2017-2031
- Table 03: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Allylamine, 2017-2031
- Table 04: U.S. OTC Topical Antifungals Market Volume (Units in Thousand) Forecast, by Drug Class, 2017-2031
- Table 05: U.S. OTC Topical Antifungals Market Volume (Units in Thousand) Forecast, by Azole, 2017-2031
- Table 06: U.S. OTC Topical Antifungals Market Volume (Units in Thousand) Forecast, by Allylamine, 2017-2031
- Table 07: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Indication, 2017-2031
- Table 08: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Dosage Form, 2017-2031
- Table 09: U.S. OTC Topical Antifungals Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2031
List of Figures
- Figure 01: U.S. OTC Topical Antifungals Market Value (US$ Bn) Forecast, 2017-2031
- Figure 02: U.S. OTC Topical Antifungals Market Value Share, by Drug Class, 2022
- Figure 03: U.S. OTC Topical Antifungals Market Value Share, by Indication, 2022
- Figure 04: U.S. OTC Topical Antifungals Market Value Share, by Dosage Form, 2022
- Figure 05: U.S. OTC Topical Antifungals Market Value Share, by Region, 2022
- Figure 06: U.S. OTC Topical Antifungals Market Value Share Analysis, by Drug Class, 2022 and 2031
- Figure 07: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Azole, 2017-2031
- Figure 08: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Allylamine, 2017-2031
- Figure 09: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Tolnaftate, 2017-2031
- Figure 10: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Undecylenic Acid, 2017-2031
- Figure 11: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Others, 2017-2031
- Figure 12: U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Drug Class, 2023-2031
- Figure 13: U.S. OTC Topical Antifungals Market Value Share Analysis, by Indication, 2022 and 2031
- Figure 14: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Ringworm, 2017-2031
- Figure 15: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Undecylenic Acid, 2017-2031
- Figure 16: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Athlete's Foot, 2017-2031
- Figure 17: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Others, 2017-2031
- Figure 18: U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Indication, 2023-2031
- Figure 19: U.S. OTC Topical Antifungals Market Value Share Analysis, by Dosage Form, 2022 and 2031
- Figure 20: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Creams, 2017-2031
- Figure 21: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Gels, 2017-2031
- Figure 22: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Ointment, 2017-2031
- Figure 23: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Others, 2017-2031
- Figure 24: U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Indication, 2023-2031
- Figure 25: U.S. OTC Topical Antifungals Market Value Share Analysis, by Dosage Form, 2022 and 2031
- Figure 26: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Hospital Pharmacies, 2017-2031
- Figure 27: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Retail Pharmacies, 2017-2031
- Figure 28: U.S. OTC Topical Antifungals Market Revenue (US$ Mn), by Online Pharmacies, 2017-2031
- Figure 29: U.S. OTC Topical Antifungals Market Attractiveness Analysis, by Distribution Channel, 2023-2031
- Figure 30: Global OTC Topical Antifungals Market Share, by Company, 2022
